Last updated: 15:54
No Notes Added Yet
Vasa Denticity Ltd is a dynamic and innovative company specializing in advanced dental solutions. With a commitment to revolutionizing oral healthcare, Vasa Denticity combines cutting-edge technology, skilled professionals, and a patient-centered approach to deliver exceptional dental services. The company offers a comprehensive range of dental treatments, including general dentistry, cosmetic dentistry, orthodontics, oral surgery, and implantology. Using state-of-the-art equipment and advanced techniques, Vasa Denticity ensures precise diagn...Read More
Vasa Denticity Ltd is a dynamic and innovative company specializing in advanced dental solutions. With a commitment to revolutionizing oral healthcare, Vasa Denticity combines cutting-edge technology, skilled professionals, and a patient-centered approach to deliver exceptional dental services. The company offers a comprehensive range of dental treatments, including general dentistry, cosmetic dentistry, orthodontics, oral surgery, and implantology. Using state-of-the-art equipment and advanced techniques, Vasa Denticity ensures precise diagnoses, efficient procedures, and optimal patient comfort. Vasa Denticity prides itself on its highly qualified and experienced team of dentists, hygienists, and support staff who are dedicated to providing personalized care and outstanding results. The company prioritizes ongoing education and professional development to stay at the forefront of dental advancements. Committed to fostering long-term relationships with patients, Vasa Denticity emphasizes open communication, transparency, and empathy throughout the treatment journey. Their mission is to enhance smiles, improve oral health, and ultimately enhance the overall well-being of their patients. ...Read Less
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Market Cap ₹787 Cr.
Stock P/E 46.6
P/B 4.6
Current Price ₹454
Book Value ₹ 97.8
Face Value 10
52W High ₹690
Dividend Yield 0%
52W Low ₹ 322.5
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
| #(Fig in Cr.) | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 41 | 37 | 57 | 54 | 59 | 63 | 73 | 61 | 73 | 72 |
| Other Income | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 1 | 1 |
| Total Income | 42 | 37 | 57 | 54 | 60 | 63 | 73 | 61 | 74 | 73 |
| Total Expenditure | 37 | 33 | 49 | 49 | 53 | 57 | 67 | 57 | 67 | 70 |
| Operating Profit | 5 | 4 | 9 | 5 | 7 | 6 | 7 | 4 | 6 | 3 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 4 | 3 | 8 | 5 | 7 | 5 | 6 | 4 | 6 | 2 |
| Provision for Tax | 1 | 1 | 2 | 1 | 2 | 1 | 2 | 1 | 1 | 1 |
| Profit After Tax | 4 | 2 | 6 | 3 | 5 | 4 | 4 | 3 | 5 | 1 |
| Adjustments | 0 | 0 | -0 | 0 | -0 | -0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 4 | 2 | 6 | 3 | 5 | 4 | 4 | 3 | 5 | 1 |
| Adjusted Earnings Per Share | 2.3 | 1.5 | 4 | 2.1 | 3.4 | 2.4 | 2.5 | 1.7 | 2.8 | 0.8 |
| #(Fig in Cr.) | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|
| Net Sales | 172 | 249 | 279 |
| Other Income | 1 | 2 | 3 |
| Total Income | 173 | 251 | 281 |
| Total Expenditure | 153 | 226 | 261 |
| Operating Profit | 21 | 26 | 20 |
| Interest | 0 | 0 | 0 |
| Depreciation | 1 | 2 | 2 |
| Exceptional Income / Expenses | 0 | 0 | 0 |
| Profit Before Tax | 19 | 24 | 18 |
| Provision for Tax | 4 | 7 | 5 |
| Profit After Tax | 15 | 17 | 13 |
| Adjustments | 0 | 0 | 0 |
| Profit After Adjustments | 15 | 17 | 13 |
| Adjusted Earnings Per Share | 9.4 | 10.2 | 7.8 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 45% | 0% | 0% | 0% |
| Operating Profit CAGR | 24% | 0% | 0% | 0% |
| PAT CAGR | 13% | 0% | 0% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -27% | NA% | NA% | NA% |
| ROE Average | 18% | 20% | 20% | 20% |
| ROCE Average | 24% | 26% | 26% | 26% |
| #(Fig in Cr.) | Mar 2024 | Mar 2025 |
|---|---|---|
| Shareholder's Funds | 68 | 133 |
| Minority's Interest | 0 | 1 |
| Borrowings | 0 | 0 |
| Other Non-Current Liabilities | 1 | 0 |
| Total Current Liabilities | 16 | 17 |
| Total Liabilities | 85 | 151 |
| Fixed Assets | 2 | 16 |
| Other Non-Current Assets | 2 | 9 |
| Total Current Assets | 81 | 126 |
| Total Assets | 85 | 151 |
| #(Fig in Cr.) | Mar 2024 | Mar 2025 |
|---|---|---|
| Opening Cash & Cash Equivalents | 1 | 4 |
| Cash Flow from Operating Activities | -11 | -4 |
| Cash Flow from Investing Activities | -22 | -43 |
| Cash Flow from Financing Activities | 36 | 47 |
| Net Cash Inflow / Outflow | 3 | 1 |
| Closing Cash & Cash Equivalent | 5 | 4 |
| # | Mar 2024 | Mar 2025 |
|---|---|---|
| Earnings Per Share (Rs) | 9.41 | 10.21 |
| CEPS(Rs) | 10.04 | 11.21 |
| DPS(Rs) | 0 | 0 |
| Book NAV/Share(Rs) | 42.67 | 71.95 |
| Core EBITDA Margin(%) | 11.1 | 9.57 |
| EBIT Margin(%) | 11.34 | 9.65 |
| Pre Tax Margin(%) | 11.29 | 9.61 |
| PAT Margin (%) | 8.77 | 6.78 |
| Cash Profit Margin (%) | 9.36 | 7.47 |
| ROA(%) | 17.68 | 14.32 |
| ROE(%) | 22.06 | 17.98 |
| ROCE(%) | 28.5 | 23.93 |
| Receivable days | 23.93 | 18.4 |
| Inventory Days | 72.13 | 64.17 |
| Payable days | 33.1 | 23.31 |
| PER(x) | 52.09 | 61.11 |
| Price/Book(x) | 11.49 | 8.67 |
| Dividend Yield(%) | 0 | 0 |
| EV/Net Sales(x) | 4.49 | 4.14 |
| EV/Core EBITDA(x) | 37.64 | 40.04 |
| Net Sales Growth(%) | 0 | 45.08 |
| EBIT Growth(%) | 0 | 23.39 |
| PAT Growth(%) | 0 | 12.09 |
| EPS Growth(%) | 0 | 8.45 |
| Debt/Equity(x) | 0 | 0 |
| Current Ratio(x) | 4.95 | 7.57 |
| Quick Ratio(x) | 2.88 | 4.34 |
| Interest Cover(x) | 207.66 | 226.77 |
| Total Debt/Mcap(x) | 0 | 0 |
| # | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 69.62 | 69.62 | 69.62 | 69.62 | 69.3 | 66.5 | 65.97 | 65.6 | 60.75 | 60.19 |
| FII | 0 | 0 | 0 | 0.02 | 0.22 | 3.54 | 3.53 | 3.56 | 7.5 | 6.93 |
| DII | 1.69 | 0.65 | 0.64 | 0.23 | 1.28 | 1.72 | 1.77 | 0.91 | 0.87 | 1.66 |
| Public | 28.69 | 29.73 | 29.74 | 30.13 | 29.2 | 28.24 | 28.73 | 29.92 | 30.88 | 31.23 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 1.12 | 1.12 | 1.12 | 1.12 | 1.11 | 1.11 | 1.1 | 1.09 | 1.05 | 1.04 |
| FII | 0 | 0 | 0 | 0 | 0 | 0.06 | 0.06 | 0.06 | 0.13 | 0.12 |
| DII | 0.03 | 0.01 | 0.01 | 0 | 0.02 | 0.03 | 0.03 | 0.02 | 0.02 | 0.03 |
| Public | 0.46 | 0.48 | 0.48 | 0.48 | 0.47 | 0.47 | 0.48 | 0.5 | 0.54 | 0.54 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1.6 | 1.6 | 1.6 | 1.6 | 1.6 | 1.66 | 1.66 | 1.66 | 1.73 | 1.73 |
* The pros and cons are machine generated.
You May Also Know About
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
ChatGPT
Claude
Perplexity
